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A B S T R A C T  
Recently, diterpenoids from various Euphorbiaceae species, such as phorbol esters, have been shown 
to be potent inhibitors of chikungunya virus (CHIKV) replication. To discover new natural inhibitors 
of chikungunya virus (CHIKV) replication, forty-five extracts prepared from various plant parts of 11 
Euphorbiaceae species (Euphorbia and Mercuralis genus) were evaluated for antiviral effect against 
CHIKV in a virus-cell-based assay. All EtOAc extracts from Euphorbia species exhibited potent and 
selective anti-CHIKV activity, latex extracts proved to be the most potent inhibitors. A LC-MS2-based 
dereplication strategy was established for the detection in the active extracts of known substances 
displaying potent antiviral activity such as 12-O-tetradecanoylphorbol-13-acetate (TPA) (13), phorbol-
12,13-didecanoate (11) and prostratin (21), and twenty-four other commercially available diterpenoids 
of tigliane-, ingenane- and daphnane-type. This approach allowed the identification of three 
compounds in Euphorbia extracts: ingenol-3-mebutate in E. peplus, 13-O-isobutyryl-12-
deoxyphorbol-20-acetate in E. segetalis ssp. pinea and ingenol-3,20-dibenzoate in E. peplus and E. 
pithyusa ssp. pithyusa. Known potent inhibitors of CHIKV replication such as phobol esters were not 
identified in the Euphorbia extracts. Thus, the present study suggested that untargeted diterpene esters 
are responsible for the antiviral properties of the Euphorbia extracts. 
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1. Introduction 
Chikungunya fever is caused by an arthropod-borne virus that is associated with massive epidemics 
and severe morbidity (virus-induced arthralgia, fever, myalgia and rashes). Worldwide expansion of 
the mosquito vectors Aedes aegypti and A. albopictus is responsible for the spread of chikungunya 
virus (CHIKV) from Africa and the Indian subcontinent to Southeast Asia, around the Indian Ocean, 
and more recently to the Caribbean islands, Central and South America [1–3]. Currently, no antiviral 
drugs or vaccines are available for the treatment or prevention of CHIKV infection [4]. Recent 
scientific reviews have highlighted issues and latest developments in the search for new therapeutic 
solutions [5,6]. 
In an effort to identify novel inhibitors of CHIKV replication, Euphorbiaceae species have been 
selected and investigated by means of bioassay-guided purification, which resulted in the isolation of 
daphnane- and tigliane-type esters with anti-CHIKV activity [7,8]. In particular, tigliane-type esters 
such as 12-O-tetradecanoylphorbol-13-acetate (TPA) (13), phorbol-12,13-didecanoate (11) and 
prostratin (21) were found to be potent and selective inhibitors of CHIKV and HIV replication in vitro 
[9,10] However, TPA along with other phorbol esters are known to possess pro-inflammatory and 
tumor-promoting activities [11–14] through broad activation of PKCs (Protein kinase C isoenzymes) 
[15,16]. 
The genus Euphorbia is the largest genus in the family Euphorbiaceae with over 2.000 species, 
ranging from prostrate annuals, cactus-like succulents to tall trees [17]. In Europe, this genus is 
represented by more than hundred species that mainly belong to the subgenus (subg.) Esula Pers., 
which vary from annual herbs to small shrubs growing in the wild in Mediterranean region [18,19]. In 
Corsica, the Euphorbia genus consists of 33 taxa, of which 22 are endemic to Euro-Mediterranean 
areas [20]. Spurges (Euphorbia spp.) produce an irritant milky-white sap (latex), which acts as a 
chemical defense barrier when the plant is wounded. The toxicity of the latex to the skin, mucosae and 
eyes has been known since ancient time [21] and is still a common cause of gardening mishaps [22]. 
According to Greek and Roman literature, medical utilization of spurges included treatment of 
cancerous conditions, relieve of chronic pain and as drastic purgative [21,23]. In Corsica, an 
ethnobotanical study revealed that latex of Euphorbia spp. was traditionally used as vesicant agent to 
remove warts [24]. In Sardinia and in Central Italy, ethnobotanical studies reported that E. characias 
and E. rigida were used as fish poison to flush out the eels which other while would suffocate [25,26]. 
Diterpenoids isolated from Euphorbia species represent a unique group of structurally diverse 
compounds that possess remarkable biological activities [27–31], such as potent antiviral activity 
against human immunodeficiency virus (HIV) for tigliane-[32], ingenane- [28,33,34] and macrocyclic-
type esters [35–37], or powerful P-glycoprotein modulation activity for macrocyclic diterpene esters 
[38,39].  
The recent launch of Picato® (ingenol-3-mebutate), a broad PKC modulator isolated from E. peplus 
for the treatment of precancerous skin condition (actinic keratosis), highlights the therapeutic potential 
of diterpene esters [40]. In addition, EBC-46, a tigliane-type diterpene ester, was able to induce 
regression and ultimate cure of diverse tumors following a single intra-lesional injection in a pre-
clinical model for cancer [41]. 
Several LC-MS based methods targeting commercial and isolated compounds were developed in 
order to monitor diterpene esters of tigliane [42,43], ingenane [42,44–46], lathyrane [46–48] and 
daphnane-types [49,50].  
In the present study, 45 extracts from different plant parts of eleven Euphorbiaceae (including ten 
Euphorbia and one Mercurialis species) were evaluated for selective inhibition of CHIKV in a virus-
cell-based assay. In a dereplication perspective, a targeted LC-MS2-based method was developed for 
the detection of 27 diterpene esters possessing antiviral properties (anti-CHIKV and/or anti-HIV) [10], 
or known to possess PKC modulation ability, pro-inflammatory and tumour-promotion activities. The 
bioactivity guided-fractionation procedure performed on an EtOAc extract of E. amygdaloides ssp. 
semiperfoliata was performed following the work presented herein [51]. 
  
2. Experimental 
2.1. Plant material 
The samples of various Euphorbiaceae were collected on different locations in Corsica Island 
(France) during July and August 2011 (Table 1). The botanical identification of the species has been 
established by Louis-Félix Nothias-Scaglia. A voucher specimen for each species has been deposited 
at the Herbarium of the CPN laboratory at the University of Corsica (Corte). 
 
2.2. Extract preparation 
Harvested plants were air-dried for a period of three weeks at ambient temperature. The vegetal 
parts were powdered using a blade miller (PX-MCF 90D Kinematica). All the samples were extracted 
with 3 x 100 mL of ethyl acetate (EtOAc) and subsequently, with 3 x 100 mL of methanol (MeOH) 
using an automatic solvent extractor (ASE 200). For each solvent, a maceration was carried out during 
15 min at 40 °C and 34 bar. The solution was evaporated to dryness in vacuo yielding dried extract.  
The latex were collected into EtOH after making cuts on stalks. A whitish precipitate was removed 
from the latex by cotton filtration. Filtrates were evaporated to dryness in vacuo yielding crude extract. 
The laths were partitioned by liquid-liquid extraction with EtOAc and water. For some latex, an 
emulsion was observed during liquid-liquid partition and thus, the solution was evaporated to dryness 
using a rotary evaporator and solid-liquid extractions were performed using EtOAc. All extracts were 
stored at 4°C until analysis. Solvents and others chemicals were purchased from VWR (France). The 
samples used for LC-MS2 analysis were prepared by dissolving the extracts in MeOH at 2.5 mg/mL, 
and then filtered on 0.2 µm PTFE filter. 
 
2.3. MS2 and LC-MS2 analysis 
2.3.1. Chemicals and standard compounds  
Solvents and reagents used for sample preparation and chromatography were LC-MS grade: 
acetonitrile (ACN), methanol (MeOH), and ammonium acetate (NH4AcO) were obtained from Fisher 
Scientific (Illkirch, FR). Deionized water was purified by Milli-Q water Millipore (Bedford, USA) 
purification system. All reference compounds 1-24 and 26-27 (98% purity by LC) were purchased 
from Santa Cruz Biotechnology Inc (Heidelberg, Germany) except ingenol-3-angelate 25 (98% purity 
by LC), which was purchased from Coger SAS (Paris, France). Solutions of reference compounds 
were prepared by dissolving each component in MeOH at 1 mg/mL and then filtered on 0.2 µm PTFE 
filter. Flow injection analysis (FIA) were performed with reference solutions at a concentration of 0.1 
mg/mL in 8:2 ACN/H2O + 0,1 % NH4AcO.  
 
2.3.2. Analysis by flow injection analysis MS (FIA) 
Experiments were performed using a 3200 QTRAP AB Sciex (Framingham, MA, USA) linear triple 
quadrupole mass spectrometer fitted with ESI Turbo VTM ion source operating in positive mode. High 
purity nitrogen was used both as nebulizer and turbo gas. The ESI source parameters used for FIA 
were set as follow: CUR (curtain gas), 10 psi; CAD (collision gas), high; GS1 (nebulizer gas), 20 psi; 
GS2 (heater gas), 0 psi; IS (ion spray voltage), 5000 V; temperature (150°C). The software used for 
data acquisition and data analysis was Analyst version 1.5.1 (Framingham, MA, USA). 
For each reference compounds, a relevant transition of pseudo-molecular ion was selected using the 
automated component optimization function of the Analyst software. The instrumental parameters 
were also optimized in direct infusion (flow rate : 10 µL/min) to achieve maximum signal/noise (S/N).  
 
2.3.3. LC-MS2 analysis  
The LC system consists of a Flexar LC PerkinElmer (Waltham, MA, USA) made up of two Flexar 
FX-10 LC pump, a Flexar solvent manager, a 275-Flexar autosampler, and a Flexar LC PE200 column 
oven. LC separations were performed on a 100×2.1 mm i.d., RP 18, 3 µm, LUNA 3U column 
(Phenomenex) and the column temperature was set at 25°C. The injected sample volume was 10 µL 
using an injection loop of 15 µL in partial loop mode. The mobile phase consisted in milliQ water 
(solvent A) and ACN (solvent B) each containing 0.1% (v/v) NH4AcO buffer. During LC analysis, the 
flow rate was set at 700 µL/min and equilibration of the column was perform by a 50% A-50% B 
elution (5 min); elution was carried out with the following steps: 50 % A-50% B for 1 min, followed 
by a linear gradient of 50-75% B during 16 min; increased from 75% B to 100% in 4 min; and 100% 
B during 10 min. The ESI source parameters were optimized to achieve maximum detection of 
diterpene esters and the following parameters were used for LC-MSn analysis: CUR (25 psi); CAD 
(high); GS1 (45 psi); GS2 (40 psi); IS (5000 V); temperature (500°C). MS2 spectra were acquired by 
an MS2 scan with the following parameters: Q1 resolution (unit), Q3 resolution (unit); DP 
(declustering potential) 70 V; EP (entrance potential) 10 V; CE (collision energy) 35 V and CES (± 15 
V). To achieve maximum sensitivity, data acquisition was performed by scanning specific precusor-
to-product transition of each standard compound in the multiple reaction monitoring (MRM), followed 
by automatic acquisition of MS2 spectrum in EPI (Enhanced Product Ion) mode. MS2-EPI mass 
spectra were recorded in the range of m/z 50-1000 at 4000 Da/s. Retention times, MRM transitions 
and multiple MS2 spectra of each standard compound were recorded into Analyst software spectral 
database. Several mixtures of standard compounds were analyzed by LC-MS2, detection and 
identification of reference solutions was allowed down to 0.10 ng/mL (i.e. 0.1 ng, injected). At lower 
concentration, MS2 spectra did not permit unambiguous compounds annotation. 
 
2.3.4. Untargeted LC-MS2 
Analyses were performed by using ion trap full scan MS through EMS (Enhanced Mass 
Spectrometry) followed by an MS2 (Enhanced Product Ion) scan triggered by IDA (Information 
Dependent Acquisition). MS Range used for EMS and MS2 experiments were m/z 100-1000. IDA 
properties were set to select 1 to 2 peaks above 30.000 counts, and with an exclusion rule after 10 
occurrences for 30 sec with dynamic background subtraction. 
2.3.5. Targeted LC-MS2 
Detection of standard compounds was performed by using MRM mode followed by an MS2 scan 
(MRM-MS2) triggered by IDA filter. For this purpose, compound-specific parameters of all reference 
compounds were optimized using the automated compound optimization function of Analyst software 
by flow injection analysis (FIA) into the source: DP, EP, CE, CXP (collision cell exit potential) (Table 
2). Retention time of reference compounds could be determined by untargeted LC-MS2 analysis of 
reference sample in chromatographic conditions described above. MS2 spectra observed by FIA and 
MRM-MS2 were recorded in Analyst spectral library. MRM-MS2 parameters were set as follow, for 
MRM experiment: detection window (180 sec), Q1 resolution (unit), Q3 resolution (low), target scan 
time (2.3 sec); MS2 scans were acquired at m/z 100-1.000. IDA properties were set to select 1 to 2 
peaks above 300 counts with an exclusion filter after 10 occurrences for 30 sec with dynamic 
background subtraction. All reference standards compounds could be detected in MRM-MS2 by 
injection of 10 µL at 10.0 ng/mL with a S/N (signal/noise ratio) above 25. Compound identification 
was allowed by comparison of retention time, observation of characteristic transition (S/N > 10) and 
by matching MS2 spectrum of the reference compounds using Analyst library. 
 
2.4. CHIKV virus-cell-based antiviral assay 
Throughout the experiments, Vero (African green monkey kidney) cells were used. Chikungunya 
virus (Indian Ocean strain 899), kindly provided by C. Drosten (Institute of Virology, University of 
Bonn, Germany), was used. Serial dilutions of the test compounds, as well as the reference 
compounds, chloroquine, were prepared in 100 µL of assay medium [MEM Rega3 (cat. no. 19993013; 
Invitrogen), 2% FCS (Integro), 5 mL of 200 mM L-glutamine, and 5 mL of 7.5% sodium bicarbonate], 
added to empty wells of a 96-well microtiter plate (Falcon, BD). Subsequently, 50 µL of a 4× virus 
dilution in assay medium was added, followed by 50 µL of a cell suspension. This suspension, with a 
cell density of 25.000 cells/50 µL, was prepared from a Vero cell line subcultured in cell growth 
medium (MEM Rega3, supplemented with 10% FCS, 5 mL of L-glutamine, and 5 mL of sodium 
bicarbonate) at a ratio of 1:4 and grown for seven days in 150 cm2 tissue culture flasks (Techno Plastic 
Products). The assay plates were returned to the incubator for 6−7 days (37 °C, 5% CO2, 95−99% 
relative humidity), a time at which maximal virus-induced cell death or cytopathic effect (CPE) is 
observed in untreated, infected controls. 
Subsequently, the assay medium was aspirated, replaced with 75 µL of a 5% MTS (Promega) 
solution in phenol red-free medium, and incubated for 1.5 h. Absorbance was measured at a 
wavelength of 498 nm (Safire2, Tecan), with the optical densities (OD values) reaching 0.6−0.8 for 
the untreated, uninfected controls. Raw data were converted to percentages of controls, and the EC50 
(50% effective concentration, or concentration calculated to inhibit virus-induced cell death by 50%) 
and CC50 (50% antimetabolic concentration, or concentration that is calculated to inhibit the overall 
cell metabolism by 50%) values were derived from the dose−response curves. All assay conditions 
producing an antiviral effect that exceeded 50% were checked microscopically for signs of a 
cytopathic effect or adverse effects on the host cell (i.e., altered cell or monolayer morphology). A 
sample was considered to elicit a selective antiviral effect on virus replication only when, following 
microscopic quality control, at least at one concentration no CPE or any adverse effect was observed 
(image resembling untreated, uninfected cells). Multiple, independent experiments were performed. 
The antiviral experiments have been performed in a biosafety screening facility that has been validated 
for handling of chikungunya virus as well as the manipulation of molecules of unknown chemical 
safety risk. All studies have been performed by trained staff. 
 
 
3. Results and discussion 
3.1. Evaluation of Euphorbia extracts for selective inhibition of CHIKV replication 
A total of 45 extracts were prepared from different parts of eleven Euphorbiaceae species growing 
wild on Corsica Island (Table 1). These extracts were evaluated for selective anti-CHIKV activity in a 
virus-cell-based assay (Table 2 and Table 3). As shown in Table 2, EtOAc extracts of latex from nine 
Euphorbia species exhibited a significant and selective antiviral effect on CHIKV replication (EC50s < 
2.1 µg/ml and SI > 31). Whereas, beside the extract prepared from E. dendroides latex, no aqueous 
extracts showed any potent anti-CHIKV activity (EC50 > 100 µg/ml). 
  
Table 1 
Taxonomic classification of 11 Euphorbiaceae species, and their place of harvesting in Corsica 
 
subgenus section species distribution areaa altitude (location) 
voucher 
reference 
Chamaesyce  Euphobia maculata L. Nat. America 70 m (Palasca) LF-022 
Esula Aphyllis Euphorbia biumbellata Poir. W-Stenomed 240 m (Ota) LF-014 
Esula Aphyllis Euphorbia dendroides L. W-Stenomed 30 m (Piana) LF-018 
Esula Conicocarpae Euphorbia pithyusa L.  
ssp. pithyusa 
W-Stenomed 15 m (Rogliano) LF-004 
Esula Helioscopia Euphorbia hyberna L.  
ssp. insularis (Boiss.) Briq. 
Corsica, Sardinia 1200 m (Albertacce) LF-013 
Esula Helioscopia Euphorbia spinosa L. N-Eurymed 750m (Sermano) LF-019 
Esula Paralias Euphorbia segetalis L. 
ssp. pinea (Hayek) 
W-Stenomed 100 m (Rogliano) LF-010 
Esula Patellares Euphorbia amygdaloides L.  
ssp. semiperfoliata (Viv.) 
Corsica, Sardinia 1300 m (Albertacce) LF-015 
Esula Patellares Euphorbia characias L.  
ssp. characias 
Stenomed 500 m (Corte) LF-001 
Esula Peplus Euphorbia peplus L. Eurosiberian 50 m (Rogliano) LF-012 
  Mercurialis annua L. Eur. N-Africa 150 m (Rogliano) LF-009 
a Nat. America: Naturalized America;  
  W-Stenomed: Stenomediterranean from Spain to Liguria and Tunisia;  
  N-Stenomed: Stenomediterranean from Spain to Greece;  
  N-Eurymed: Eurymediterranean from Spain to Greece;   
  Stenomed: mediterranaen periphery; 
  Eur. N-Africa: Eurasia and North Africa. 
  
Table 2  
Anti-CHIKV activity of 15 extracts from 9 Euphorbia latex (EC50 and CC50 in µg/mL)b 
 
species  plant parts extractsa 
CHIKV 
(EC50) 
Vero cells 
(CC50)  
SIc 
E. maculata Latex LLE EtOAc < 0.8 > 100 > 128 
  LLE H2O > 100 n.d. n.d. 
E. biumbellata Latex SLE EtOAc 2.1 ± 1.4 > 100 > 47 
E. dendroides Latex LLE EtOAc < 0.8 25.0  ± 5.2 > 32 
  LLE H2O 1.1 70.7 ± n.d. 59 
E. pithyusa ssp. pithyusa Latex LLE EtOAc < 0.1 10.6 ± 2.9 > 75 
  LLE H2O 30.7 > 100 > 3.3 
E. hyberna ssp. insularis Latex LLE EtOAc < 0.8 23.8 ± 7.3 > 31 
  LLE H2O > 100 n.d. n.d. 
E. spinosa Latex SLE EtOAc < 0.8 25.9 ± 4.8 > 32 
E. amygdaloides ssp. semiperfoliata Latex SLE EtOAc < 0.8 34.3 ± 1.8 > 44 
E. characias ssp. characias Latex LLE EtOAc 0.4 ± 0.2 16.8 ± 5.0 39 
  LLE H2O > 100 n.d. n.d. 
E. peplus Latex LLE EtOAc < 0.8 50.3 ± 14.9 > 65 
  LLE H2O > 100 n.d. n.d. 
chloroquine (positive control)   10 ± 5 µM n.d. 9 
a SLE: solid-liquid extraction, LLE: liquid-liquid extraction. 
b EC50 : 50% effective concentration, CC50 : 50% anti-metabolic concentration. Values are the median ± 
median absolute deviation calculated from at least 3 independent assays. 
 
For each Euphorbia species, the EtOAc latex extract displayed higher anti-CHIKV activity than the 
EtOAc extracts obtained from plant parts (Table 3). Furthermore, EtOAc extracts of all plant parts 
from eight Euphorbia species showed potent anti-CHIKV activity (EC50s < 6.9 µg/ml and SI > 5) 
whereas the EtOAc and MeOH extracts of Mercurialis annua showed weak and no anti-CHIKV 
activity (EC50 = 40 ± 4, and > 100 µg/ml, respectively). Moreover, the comparison of results obtained 
for various plant parts (whole plant, aerial parts, leaves, stems, roots) of Euphobia species highlighted 
that the EtOAc extracts were systematically more active than subsequent MeOH extracts. For instance, 
the EtOAc extract of E. pithyusa ssp. pithyusa leaves exhibited more potent anti- CHIKV activity 
(EC50 < 0.8 µg/ml, SI > 24) than the corresponding MeOH extract (EC50 = 23 µg/ml, SI = 1).  
Based on selectivity indices (SI) and on systematic microscopic inspection of the antiviral assays, it 
was confirmed that the antiviral activities found for the Euphorbia extracts were selective. Indeed, no 
significant alteration of cell or monolayer morphology was observed in comparison with the untreated 
uninfected controls.  
  
Table 3 
Anti-CHIKV activity of 30 MeOH and EtOAc extracts of 8 Euphorbia species and Mercurialis annua 
(EC50 and CC50 in µg/mL)c 
 
species plant parts extractsa yield (%)b 
CHIKV 
(EC50) 
Vero cells 
(CC50) 
SId 
E. biumbellata  Whole plant ASE EtOAc 4.4 4.1 > 100 > 47 
  ASE MeOH 6.7 > 100 n.d. n.d. 
E. pithyusa ssp. pithyusa Leaves ASE EtOAc 6.0 < 0.8 18.8 ± 1.2 > 24 
 ASE MeOH 11.0 23.0 23.3 ± 2.8 1 
 Stems ASE EtOAc 4.6 < 0.8 15.2 ± 5.9 > 20 
  ASE MeOH 9.0 4.5 8.5 ± 0.4 2 
 Roots ASE EtOAc 4.0 < 0.8 11.5 ± 1.6 > 15 
  ASE MeOH 8.0 < 0.8 21.0 ± 4.5 > 27 
E. hyberna ssp. insularis Aerial parts ASE EtOAc 3.9 1.0 35.5 ± 3.1 36.0 
E. spinosa Leaves ASE EtOAc 1.0 4.8 30.9 ± 2.2 6.4 
 Stems ASE EtOAc 5.0 3.4 23.2 ± 8.2 6.8 
 ASE MeOH 8.7 20.3 33.0 ± 2.4 1.6 
 Roots ASE EtOAc 7.0 < 0.8 30.5 ± 2.4 > 39.1 
  ASE MeOH 4.8 2.3 54.1 ± 18.0 23.5 
E. segetalis ssp. pinea Aerial parts ASE EtOAc 7.0 3.7  35.6 ± 1.6 9.6 
 ASE MeOH 9.0 35.9 89.1 ± 5.1 2.5 
 Stems ASE EtOAc 3.6 3.5 25.8 ± 3.5 7.5 
 ASE MeOH 5.5 57.0 > 100 > 1.7 
 Roots ASE EtOAc 4.3 1.8 30.6 ± 0.2 17.3 
 ASE MeOH 5.9 29.7 > 100 > 3.4 
E. amygdaloides ssp semiperfoliata Whole plant ASE EtOAc 5.2 < 0.8 30.5 ± 2.4 > 39.1 
 ASE MeOH 8.0 30.6 > 100 > 3.3 
E. characias ssp. characias Leaves ASE EtOAc 6.3 6.9 34.0  ± 0.8 5.0 
 ASE MeOH 8.3 8.3 70.3  ± 3.4 8.5 
 Stems ASE EtOAc 5.0 2.9 32.1  ± 0.3 11.2 
 ASE MeOH 3.4 8.3 70.7  ± 8.5 8.5 
E. peplus Whole plant ASE EtOAc 7.4 4.3 63.1 ± 7.0 14.7 
  ASE MeOH 7.3 30.0 > 100 > 3.3 
Mercurialis annua Whole plant ASE EtOAc 3.1% 40 ± 4 89.1 ± 5.4 2 
  ASE MeOH 6.7% > 100 n.d. - 
chloroquine (positive control)   10 ± 5 µM n.d. 9 
a SLE: solid-liquid extraction, LLE: liquid-liquid extraction, ASE: automatic solvent extraction. 
b based on the dry weight of vegetal material (%); n.d.: not determined. 
c EC50 : 50% effective concentration, CC50 : 50% anti-metabolic concentration. Values are the median ± median 
absolute deviation calculated from at least 3 independent assays. 
 d SI : selectivity index (SI calculated as CC50Vero/EC50 CHIKV). 
 
Taking into account of these results, it is likely that the anti-CHIKV activities of Euphorbia extracts 
are due to specific secondary metabolites of this genus. Previous studies have showed that Euphorbia 
extracts can exhibit antiviral [52–56], but never against CHIKV replication. Diterpenoids of tigliane-
[32], ingenane- [28,33,34] and macrocyclic-type esters [35–37] isolated from various Euphorbia 
species, were found to possess potent and selective anti-HIV activities. Regarding anti-CHIKV 
activity of diterpenes from Euphorbiaceae, phorbol esters are the most potent inhibitors of CHIKV 
replication [10] but are also known for their pro-inflammatory and tumour promoter activities [13,12]. 
 
3.2. Analysis of Euphobia extracts using targeted LC-MS2 method  
In order to perform a dereplication strategy on Euphorbia extracts with potent anti-CHIKV activity, 
a LC-MS2-based method had been developed to detect 27 commercially available natural diterpenoids 
(1-27) belonging to tigliane- (phorbol and deoxyphorbol derivatives), ingenane- and daphnane-types 
(Figure 1). For each standards, MS/MS optimized parameters (precursor-to-product transition 
monitored, declustering potential DP, entrance potential EP, collision cell entrance potential CEP, 
collision energy CE, collision cell exit potential CXP), and retention time in LC, had been determined 
and are summarized in Table 4. Main ions observed in MS2 spectrum are also included in Table 4. The 
fragmentation behavior of diterpene esters were consistent with previous data reported in the literature 
[42,43,46,47], Indeed, in ESI positive ion mode, diterpene esters form pseudo-molecular ions, which 
undergo neutral loss of their acyl chain(s) under collision-induced dissociation (CID), producing the 
corresponding high-abundance fragment ions. 
The identification of diterpenoids in plant extracts was established by comparison with reference 
compounds: MRM transition at specific retention time and MS2 spectrum of the precursor ion to those 
recorded in the Analyst software spectral library. In addition, to avoid artefactual detection, an 
untargeted LC-MS2 (MRM-MS2) analysis was systematically carried out to confirm that the supposed 
targeted pseudo-molecular ion was not formed from a parent compound with a higher molecular 
weight. 
  
 no. compound R1 R2 R3 
1 phorbol HO- HO- HO- 
2 phorbol-12-acetate AcO- HO- HO- 
3 phorbol-12-decanoate DecO- HO- HO- 
4 phorbol-13-acetate HO- AcO- HO- 
5 phorbol-13-butyrate HO- BuO- HO- 
6 phorbol-13-decanoate HO- DecO- HO- 
7 phorbol-13-tetradecanoate HO- Tetradec
O- 
HO- 
8 phorbol-12,13-diacetate AcO- AcO- HO- 
9 phorbol-12,13-dibutyrate BuO- BuO- HO- 
10 phorbol-12,13-dihexanoate HO- HO- HO- 
11 phorbol-12,13-didecanoate DecO- DecO- HO- 
12 4α-phorbol-12,13-didecanoate  DecO- DecO- HO- 
13 12-O-tetradecanoylphorbol-13-acetate (TPA) TetradecO- AcO- HO- 
14 12-O-tetradecanoyl-4α-phorbol-13-acetate (4α-TPA) TetradecO- AcO- HO- 
15 12-O-tiglylphorbol-13-decanoate TiglO- DecO- HO- 
16 12-O-(N-methylanthranilate)phorbol-13-acetate MA- AcO- HO- 
17 phorbol-13,20-diacetate HO- AcO- AcO- 
18 phorbol-12,13,20-triacetate AcO- AcO- HO- 
19 20-oxo-phorbol-12,13-dibutyrate BuO- BuO- =O 
20 20-oxo-TPA  TetradecO- AcO- =O 
21 12-deoxyphorbol-13-acetate (prostratin)  AcO- HO- 
22 13-O-isobutyryl-12-deoxyphorbol-20-acetate  BuO- AcO- 
23 13-O-phenylacetyl-12-deoxyphorbol-20-acetate  PhAcO- AcO- 
24 ingenol  HO- HO-  
25 ingenol-3-mebutate MbO- HO-  
26 ingenol-3,20-dibenzoate BzO- BzO-  
27 resiniferatoxin    
Fig. 1. Structures of diterpenoids used for the targeted LC-MSn method 
Table 4 
LC-MSn parameters for reference standards in ESI positive ion mode 
 
cpd Rt 
(min) 
Q1 Mass 
(m/z)b 
Q3 Mass 
(m/z)c 
DP 
(V) 
EP 
(V) 
CEP 
(V) 
CE 
(V) 
CXP 
(V) 
Most abundant ions (m/z) observed in 
MS2 spectrum 
1 1.4 387.2 369.3 156 11.5 18 21 6 369, 351, 333, 315, 311, 293 
2 2.0 429.2 369.2 56 8.0 20 21 6 369, 351, 333, 329, 315, 311, 293 
3 13.9 541.3 369.2 86 4.5 30 25 6 369, 351, 333, 329, 315, 311, 293 
4 2.0 429.2 369.2 71 8.0 30 21 6 369, 351, 333, 329, 315, 311, 293 
5 2.6 457.2 369.2 236 10 24 25 6 369, 351, 333, 329, 315, 311, 293 
6 12.9 541.3 369.2 86 4.5 20 27 6 369, 351, 333, 329, 315, 311, 293 
7 21.5 597.3 369.2 231 4.5 62 29 6 369, 351, 333, 329, 315, 311, 293 
8 3.1 471.2 411.2 266 9.5 24 23 6 411, 351, 333, 329, 315, 311, 293 
9 9.4 527.3 439.3 71 5.0 24 25 6 439, 421, 351, 333, 329, 315, 311, 293 
10 17.7 583.3 467.2 301 6.5 30 25 6 467, 351, 333, 329, 315, 311, 293 
11 28.5 695.5 523.3 91 9.0 50 29 8 523, 351, 333, 329, 315, 311, 293 
12 29.0 695.5 523.3 211 10.5 24 45 6 523, 351, 333, 329, 315, 311, 293 
13 23.5 639.4 411.2 71 8.5 44 29 6 579, 411, 351, 333, 329, 315, 311, 293 
14 24.4 639.4 411.2 71 8.5 44 29 6 579, 411, 351, 333, 329, 315, 311, 293 
15 22.2 623.4 523.3 206 9.0 30 27 6 523, 451, 351, 333, 329, 315, 311, 293 
16 9.3 562.2 411.2 301 5.0 24 25 6 411, 502, 351, 333, 329, 315, 311, 293 
17 2.8 471.2 411.2 266 9.5 24 23 6 411, 351, 333, 329, 315, 311, 293 
18 5.8 513.2 453.2 66 4.5 20 25 6 453, 393, 365, 333,  315, 311, 293 
19 3.5 525.2 437.2 71 6.0 20 27 8 437, 349, 331, 309, 291 
20 24.0 637.3 409.2 71 8.0 27 27 6 577, 409,  349, 331, 309, 291 
21 3.3 413.2 353.2 156 8.0 24 21 6 353, 335, 317, 313, 307, 295 
22 11.3 483.2 395.2 71 7.0 22 25 6 335, 317, 313, 307, 295 
23 11.7 531.2 395.2 116 8.0 26 27 6 335, 317, 313, 307, 295 
24 3.0 371.1 353.2 261 10.0 28 23 6 353, 335, 317, 313, 307, 295, 285 
25 12.4 453.2 353.2 126 7.5 20 23 6 353, 335, 317, 313, 307, 295, 285 
26 18.2 579.4 457.2 96 9.0 28 27 6 457, 335, 317, 313, 307, 295, 285 
27 16.3 651.3 515.2 266 10.5 30 33 6 515, 469, 441, 333 
LC-MS2 analysis of the EtOAc Euphorbia extracts allowed the identification of three diterpenes 
(Table 5). The results indicated that ingenol-3-mebutate (25) was present in E. peplus extracts (latex 
and whole plant). Indeed, the identification of compound 25 was allowed by the detection of a 
transition m/z 453→ 335 at Rt 12.4 min and by comparison with MS2 spectra recorded in our spectral 
library (Fig. S1). Using the same methodology, ingenol-3,20-dibenzoate (26) was detected by 
observation of a transisiton m/z 579→457  at Rt 18.3 min in E. peplus and E. segetalis ssp. pinea 
extracts (Fig S2-S3). Compound 26 was found in latex extracts as well as in other plant parts of the 
two species. Furthermore, 13-O-isobutyryl-12-deoxyphorbol-20-acetate (22) was detected in roots and 
aerial parts extracts of E. segetalis ssp. pinea (Fig S4).  
 
Table 5  
Reference standard diterpene esters detected by targeted LC-MS (MRM-MS2) (see Fig. S1-S4 for MS2 
spectra) 
 
extracts 
(EtOAc) 
plant 
partsa 
compound transition 
(m/z) 
Rt 
(min) 
[M+Na]+ 
(m/z) 
ions observed in 
MS2 spectrum 
S/N 
E. peplus 
 
Lat, 
WP 
ingenol-3,20-dibenzoate 26 579.4/457.2 18.3 579.21 457.2, 335.2 188 
ingenol-3-mebutate 25 453.2/353.2 12.4 453.22 335.2, 295.2 82 
E. pithyusa 
ssp. 
pithyusa 
Lat, 
OPP 
13-O-isobutyryl- 
12-deoxyphorbol-20-acetate 22 
483.2/395.2 11.2 483.24 423.4, 395.2, 
335.2 
85 
E. segetalis 
ssp. pinea 
R, AP  ingenol-3,20-dibenzoate 26 579.4/457.2 18.4 579.21 457.2, 335.2 145 
a Lat : latex, WP : whole plant, OPP : other plant parts, R : roots, AP : aerial parts 
 
The present results are in agreeement with the previously reported isolation of ingenol-3-mebutate 
(25) in E. peplus extract [57], and the isolation of other ingenane-type esters in E. peplus and in E. 
segetalis extracts [58,59]. The detection of 13-O-isobutyryl-12-deoxyphorbol-20-acetate (22) is also 
reinforced by the isolation of deoxyphorbol diesters in E. pithyusa ssp. pithyusa [60]. However, one 
must keep in mind that even if comparison with MS2 spectrum and Rt obtain in the same conditions is 
considered sufficient to confidently identified compound in LC-MS2 [61], it cannot be exclude that the 
ion detected is an isomer. 
Beside detection of these three compounds, no other standard compound could be detected in the 
Euphorbia extracts, including the highly potent anti-CHIKV phorbol esters 11, 13, and 21. These 
results are consistent with (i) previous phytochemical investigation of these species (Table S1) and (ii) 
the fact that, while tigliane-type diterpene are commonly found in Euphorbia spp. [27,31], occurrence 
of phorbol derivatives stricto sensu was rare in this genus [13,62,63]. Indeed, most of phorbol esters 
had been found in genus Croton [64], Jatropha [65] and Sapium [66].  
From the dereplication perspective, taking into account the IC50 values for inhibition of CHIKV 
replication of 13-O-isobutyryl-12-deoxyphorbol-20-acetate (22), and ingenol-3,20-dibenzoate (26), 
(EC50 = 0.7 ± 0.1 µM, SI = 5.0, and EC50 = 1.2 ± 0.1 µM, SI = 6.4, respectively), it can be concluded 
that the presence of compound 22 in E. pithyusa ssp. pithyusa, and  compound 26 in E. peplus and E. 
segetalis ssp. pinea  extracts should partially explain their potent anti-CHIKV activity. However, it is 
likely that other diterpene esters may contribute to the anti-CHIKV activities of these extracts. For 
instance, it has been demonstrated that jatrophane esters isolated from E. amygdaloides ssp. 
semiperfoliata exhibited significant anti-CHIKV activities [51].  
It should be noted that the diterpenes 22, 25, and 26 are potent and selective inhibitors of HIV-1 and 
HIV-2 at the nanomolar scale [10]. Thus, it is likely that the EtOAc extracts of E. peplus, E. segetalis 
ssp. pinea and E. pithyusa ssp. pithyusa possess strong anti-HIV activities. 
 
4. Conclusion 
In conclusion, several EtOAc and MeOH extracts of Euphorbia species exhibited potent and 
selective inhibitory activities of CHIKV replication. A LC-MS2 based method was used to detect the 
possible presence in the biologically active extracts of diterpene esters endowed with antiviral 
activities. The results of the LC-MS2 analysis indicated the presence of 13-O-isobutyryl-12-
deoxyphorbol-20-acetate (22) in E. pithyusa ssp. pithyusa extracts, ingenol-3-mebutate (25) in E. 
peplus extracts, ingenol-3,20-dibenzoate (26) in E. peplus and E. segetalis ssp. pinea extracts. Potent 
inhibitors of CHIKV replication such as phorbol-12,13-didecanoate (11), TPA (13) and prostratin (21) 
were not detected in the Euphorbia extracts. Thus, the present results suggested that untargeted 
diterpene esters are responsible of the anti-CHIKV activity of Euphorbia extracts.  
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